Summary
This prediction ended on 14.12.24 with a price of €570.00. With a performance of 51.60% the BUY prediction by BiotechBee was a big success. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Argenx SE | - | - | - |
| iShares Core DAX® | -1,10 % | -6,08 % | 0,87 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 18,26 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 26,34 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 13,29 % |
According to BiotechBee what are the pros and cons of Argenx SE for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Argenx SE diskutieren
Buy mit Kursziel 450,0